Structured evidence table for Flaxseed Lignans Cardiometabolic Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Flaxseed Lignans Cardiometabolic Meta-Analysis | Unhealthy aging is a growing global concern, characterized by the accelerated decline in physiological and metabolic functions, leading to increased susceptibility to age-related diseases. | 3 | Kunutsor Setor K. (2025) | Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging |
| Flaxseed Lignans Cardiometabolic Meta-Analysis | Among these are cardiometabolic diseases, including hypertension, metabolic syndrome (MetS), metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular diseases (CVDs), which collectively represent a significant public health burden. | 3 | Kunutsor Setor K. (2025) | Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging |
| Flaxseed Lignans Cardiometabolic Meta-Analysis | This condition, characterized by fat accumulation in the liver independent of alcohol consumption, often coexists with obesity, MetS, and T2D, significantly increasing the risk of liver cirrhosis and CVD []. | 3 | Kunutsor Setor K. (2025) | Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging |
Source documents